Wordt geladen...

Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer

ErbB2 is a type of receptor tyrosine kinase, which is known to be involved in tumorigenesis, tumor aggressiveness, and clinical outcome. ErbB2-targeting therapy using therapeutic antibodies has been successful in breast cancer treatment. However, the need for repeated treatments and the high cost ar...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pharmaceutics
Hoofdauteurs: Ueno, Sho, Kim, Min Woo, Lee, Gibok, Park, Yong Il, Niidome, Takuro, Lee, Ruda
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2020
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356551/
https://ncbi.nlm.nih.gov/pubmed/32599712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12060585
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!